# Recombinant Von Willebrand Factor

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Shire Pharmaceuticals Ltd
- Award value: £250,000
- Tender value: £250,000
- Award date: 12 January 2021
- Published: 22 February 2021
- Contract start: 1 February 2021
- Contract end: 30 June 2021
- Stage: awarded
- Procurement category: goods
- Notice ID: 6fd67351-d9aa-4d0d-9897-4773f8c61faf-414817
- OCID: ocds-b5fd17-73c7f75a-2d95-4205-9a33-0607288e1383

## Description

NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [NHS National Framework Agreement for the Supply of Lanadelumab](/contracts/ocds-b5fd17-9389e1ff-d0d5-4000-83f2-4a38cf241d80): NHS England
- [NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema](/contracts/ocds-b5fd17-1d6a380a-446a-4d72-ac49-db35a20e38a5): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/6fd67351-d9aa-4d0d-9897-4773f8c61faf-414817)